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Mode of actionTemporins constitute a family of amphipathic α-helical antimicrobial peptides (AMP) and contain some of
the shortest cytotoxic peptides, comprised of only 10–14 residues. General characteristics of temporins
parallel those of other AMP, both in terms of structural features and biophysical properties relating to their
interactions with membrane lipids, with selective lipid-binding properties believed to underlie the
discrimination between target vs host cells. Lipid-binding properties also contribute to the cytotoxicity
AMP, causing permeabilization of their target cell membranes. The latter functional property of AMP involves
highly interdependent acidic phospholipid-induced conformational changes, aggregation, and formation of
toxic oligomers in the membrane. These oligomers are subsequently converted to amyloid-type ﬁbers, as
demonstrated for e.g. temporins B and L in our laboratory, and more recently for dermaseptins by Auvynet et
al. Amyloid state represents the generic minimum in the folding/aggregation free energy landscape, and for
AMP its formation most likely serves to detoxify the peptides, in keeping with the current consensus on
mature amyloid being inert and non-toxic. The above scenario is supported by sequence analyses of
temporins as well as other amphipathic α-helical AMP belonging to diverse families. Accordingly, sequence
comparison identiﬁes ‘conformational switches’, domains with equal probabilities for adopting random coil,
α-helical and β-sheet structures. These regions were further predicted also to aggregate and assemble into
amyloid β-sheets. Taken together, the lipid-binding properties and structural characterization lend support
to the notion that the mechanism of membrane permeabilization by temporins B and L and perhaps of most
AMP could be very similar, if not identical, to that of the paradigm amyloid forming cytotoxic peptides,
responsible for degenerative cell loss in e.g. prion, Alzheimer's and Parkinson's disease, and type 2 diabetes.
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Antimicrobial peptides (AMP) are ubiquitously found in higher
animals, insects, arthropods, tunicates, and plants, and provide the ﬁrst
line of defence in eukaryotic innate immune system [1]. AMP
(bacteriocins) are also secreted by some bacteria [2]. AMP generally
show a wide spectrum of activity against both gram-negative and
gram-positive bacteria, yeast, and fungi, and some of them are also
haemolytic. Importantly, AMP are active against pathogens resistant to
traditional antibiotics [3], and thus offer the possibility to develop a
new class of antibiotics. In addition some AMP might be useful in
treating cancer and there are already several peptides in preclinical and
clinical trials [4]. Accordingly, detailedmolecular level understandingof
their mechanism(s) of action is needed. This task is complicated by e.g.
the fact that the sequence diversity of AMP is vast and based on their
secondary structures AMP are classiﬁed into four major classes, viz.
α-helical, β-sheet, looped, and extended peptides [5].
A large variety of peptides with a broad spectrum of antibacterial
and antifungal activities is synthesized in the skin of frogs and toads,
protecting them against invasion by pathogenic microorganisms.
Ranid frogs are a particularly rich source of AMP. Temporins were ﬁrst
identiﬁed in the skin of the Asian frog Rana erythraea and were
originally described as Vespa-like because of their sequence similarity
to chemotactic and histamine-releasing peptides isolated from the
venom of wasps of the genus Vespa. Simmaco et al. identiﬁed in
electrically stimulated skin secretions of the European common red
frog R. temporaria a family of 10 structurally related peptides with
antibacterial and antifungal properties and coined these temporins,
from A to L [6]. These AMP were isolated by screening a cDNA library
from the skin of R. temporaria using the signal peptide of the precursor
of esculentin as a probe, as similarly to other AMP also temporins are
synthesized as large precursors containing a single copy of the mature
peptide at the C-terminus, a highly conserved region comprising a 22-
residue signal peptide, and an acidic intervening propeptide sequence.
While the AMP domain at the C-terminus of the precursors is
hypervariable the above structural feature is highly conserved and is
seen even in frogs belonging to different families [7]. Temporins likely
arose through duplication from a common ancestor gene followed by
local hypermutations.
New members of the temporin family have been discovered in
extracts of the skin of other species of Rana, viz. clamitans, luteiventris,
pipiens, and grylio, and temporins now include 76 peptides (Table 1).
The characteristics of temporins make them interesting for in-depth
investigation of their biological functions and mechanisms of action.
More speciﬁcally, while some of them comprise of up to 17 amino
acids, most temporins are among the shortest amphipathic α-helical
AMP found, with a single 10–14 amino acid chain. Temporins are also
among the most highly variable of all AMP and no single amino acid
residue is invariant. All temporins isolated so far contain a prevalence
of hydrophobic amino acids and are C-terminally α-amidated. Helix-
stabilizing residues such as leucine, alanine and lysine are prepon-
derant. Temporins are also unique amongst most AMPs in having a
low net positive charge, withmost members containing basic residues
(generally Lys, alternatively His and Arg) giving a net charge ranging
from 0 to +4 at physiological pH.
The mechanisms by which temporins and AMP in general execute
their cytotoxicity are complex and remain incompletely understood. It
has become clear that AMP contribute to innate immunity by several
mechanisms, from neutralization of the lipopolysaccharide of gram-
negative bacteria to the modulation of gene expression [34].
Importantly, the all-D enantiomer of temporin A has equivalent
antibacterial activity when compared to the native peptide, indicating
that their activities are mediated via non-chiral interactions, with an
involvement of a receptor protein being unlikely [35]. Temporin L was
found to be rather non-selective, killing efﬁciently both gram-positive
and gram-negative bacteria, fungi, and cancer cells and lysingerythrocytes [36]. Studies on the interaction of temporin L with E.
coli reveal a dose-dependent increase in the permeability of the
bacterial inner membrane. At low peptide concentrations, the inner
membrane becomes permeable to small molecules but does not result
in the killing of the bacteria. However, at high peptide concentrations,
also larger molecules leak out, which causes cell death. The above
takes place without a loss of the overall structural integrity of the
target cell, with the formation of ghost-like bacteria observed by
electron microscopy [36].
The negative charge of bacterial membrane outer surface phos-
pholipids, most notably phosphatidylglycerol (PG) promotes the
binding of the cationic AMP [37] and it is currently widely believed
that a large part of their antimicrobial effect and cytotoxicity derives
from direct interactions with the lipid membrane surrounding the
target cells, causing its permeabilization. The latter action has been
explained in terms of different models, such as the carpet, barrel-
stave, toroidal pore, and detergent-type membrane lytic mechanisms
[38], all of which involve conformational changes and oligomerization
upon the interaction of AMP with lipids. The lipid-binding properties
of AMP further depend on a number of physicochemical properties
contained in their amino acid sequence, i.e. net positive charge,
amphipathicity and hydrophobicity, as well as peptide concentration-
dependent folding and aggregation in a membrane environment. The
interactions of temporins with model membranes align with the
above, although upon comparing different peptides both qualitative
and quantitative differences are evident.
In our own studies we focused on the non-haemolytic temporin B
(LLPIVGNLLKSLL-NH2) and thehaemolytic temporin L (FVQWFSKFLGRIL-
NH2). These peptides bind to and insert into the membranes and this
process is enhanced by acidic phospholipids, involving the formation of a
complex with the latter, together with augmented α-helicity of the
peptides. Their membrane insertion is accompanied by an increase in
lipid acyl chain order. The overall interaction is cooperative and involves
threshold peptide:lipid molar ratios, in keeping with the formation of
aggregated structures composed of peptide–acidic phospholipid
complexes. Finally, there is also a formation of more macroscopic,
Congo red staining ﬁbrillar aggregates, observed by microscopy. The
above characteristics of the interactions of temporin (and AMP in
general) with lipid membranes readily suggest that their sequences
should contain motifs allowing for environment dependent ‘conforma-
tional switching’ as well as aggregation. These features are expected to
be represented by relatively short stretches and be thus amenable for
sequence analyses. In the following, we will discuss the above processes
in more detail together with the underlying mechanisms providing the
respective driving forces.
2. Lipid-binding properties of temporins B and L
Temporins lack stable secondary structure in aqueous solutions yet
have the propensity to form amphipathic α-helices in a phospholipid
bilayer or in a membrane-mimetic solvent, such as triﬂuoroethanol
[39]. Accordingly, the α-helicity of temporins is augmented in the
presence of phospholipids (e.g. [40–42]). Likewise, structural studies
on temporin L in the presence of sodium dodecyl sulfate and
dodecylphosphocholine micelles using CD, NMR, and MD simulation,
show higher a propensity for α-helical structures in both membrane-
mimetic systems [43]. The amphipathic character of AMP is enhanced
upon this structural transition [38,44], with hydrophilic and hydro-
phobic side chains becoming accommodated on opposite faces of the
helix. Exposure of a hydrophobic surface is a commonmotif andmajor
driving force for the insertion of a peptide into the highly anisotropic
interface of a lipid bilayer, removing hydrophobic side chains from
water to contact the bilayer hydrocarbon region. Another contribution
to the overall reduction in free energy comes from the shielding of
peptide bonds into intramolecular H-bonds in α-helices and β-sheets
[45]. Cationic hydrophilic side chains of amphipathic α-helical
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lipids, which neutralize the excess positive charge of the surface
associated peptides and reduce peptide–peptide repulsion [46]. The
membrane bound AMP then associate to form aggregates, oligomers,
which simultaneously causemembrane permeabilization.Membranes
thus provide an environment where AMP can and must adopt
conformations and orientations, which promote peptide aggregation,
all these processes being intimately coupled.
Lipid monolayers (Langmuir-ﬁlms) residing on a gas/water inter-
face provide a very easy experimental system to study peptide–lipid
association under highly controlled conditions. More speciﬁcally, the
initial geometry of the lipid ﬁlm is restricted to 2-D, even when
containing lipids such as phosphatidylethanolamine (PE, particularly
species with cis-unsaturated chains), which because of their conical
effective molecular shape are prone in bulk systems to form inverted
phases, such as HII [47]. The lipid lateral packing density in the
monolayers is accurately controlled, which allows the extent of the
insertion of AMP into the ﬁlm to be investigated as a function of the
initial lateral packing density. This yields (i) the dependence of
peptide insertion on surface pressure, (ii) the magnitude of surface
pressure increase caused by the peptide (correlating to the change in
free energy), and (iii) the critical packing density abolishing the
intercalation of the peptide into the monolayer [48].
Monolayer experiments revealed temporin B and L to be highly
membrane active, effectively inserting into zwitterionic phosphati-
dylcholine (PC)monolayers. The lipid insertionwas augmented by the
negatively charged phosphatidylglycerol (PG), an abundant constitu-
ent of the bacterial target membranes [49]. The kinetics of the increase
in surface pressure π caused by temporin B were different from those
for temporin L and suggest a rapid conformational and/or orienta-
tional change following the initial intercalation of temporin B into the
lipid ﬁlm. These data also suggest that some PG molecules, which are
electrostatically bound to the peptides, are removed from the
phospholipid monolayer, becoming oriented with their long axis
parallel to the monolayer plane [41,50], in a manner compatible with
the orientation of lipids accommodated in the toroidal pore.
The characteristics of collisional quenching of the Trp residue of
temporin L in the presence of SOPC liposomes by the water soluble
acrylamide and phospholipids with brominated acyl chains demon-
strate that this peptide inserts in part into the hydrocarbon region of
the bilayer [41]. These data also reveal the presence of two
populations of temporin L in SOPC and POPG containing membranes,
with parallel and perpendicular orientation with respect to the plane
of the membrane surface. Trp ﬂuorescence of temporin L decreased
upon its transfer from the buffer into a SOPC membrane and the
ﬂuorescence intensity was further decreased in the presence of
cholesterol. This suggests an increase in the polarity of the environ-
ment of Trp, e.g. an increased exposure to the aqueous phase,
conﬁrmed by augmented acrylamide quenching. In order to span
the bilayer both temporin B and L would need to dimerize, with the
membrane inserted α-helices likely arranging into CN–NC dimers
oriented perpendicular to the membrane plane, i.e. the amino-termini
being juxtaposed in the bilayer center, as concluded from the
ﬂuorescence spectroscopy studies on temporin L [41].
In keepingwith theirmembrane insertion the effects of temporin B
and L on lipid dynamics in bilayers are pronounced, increment in DPH
ﬂuorescence anisotropy r revealing peptide-induced increase in acyl
chain order in the presence of PG, the magnitude of this effect
increasing with the content of the acidic phospholipid [48]. Lipid
segregation was induced in the presence of the acidic phospholipid,
with an enrichment of the latter lipid in complexes with the peptide.
All these effects comply with the importance of the acidic phospho-
lipid as well as the cationic charge of the peptides to their interaction
with membranes. Interestingly, both peptides inﬂuence the quantum
yields of pyrene-labelled lipids. For temporin L quenching of pyrene
ﬂuorescence was observed regardless of lipid composition while fortemporin B this was abolished in the presence of POPG. Both π–π
interactions between pyrene and Trp as well as contacts of the basic
residues of the peptides with the ﬂuorophore resulting in π–cation
interaction could be involved [48]. Notably, collisional quenching
stems from short range interactions. A signiﬁcant blue shift in
combination with a decrease in quantum yield suggests that Trp
residue in this case ﬂuctuates between two states, where the other
state involves a contact with a charged or polar moiety, causing a
diminished quantum yield, while the other state resides in a
hydrophobic environment and is lacking this contact.
Experiments with giant unilamellar vesicles (GUV) demonstrated,
similarly to indolicidin and magainin 2, a very rapid local aggregation
of temporins B and L after their topical application onto the surface of
the GUV membrane by microinjection, [48,50]. Yet, the targeted GUV
were not dissolved, arguing against detergent-likemechanisms. These
experiments further imply that the membrane bilayer perturbing
peptide aggregate/oligomermayexist only as a transient intermediate,
with the microinjected peptide causing the emergence inside the GUV
of a highly refractive, dense and immobile structure at the site of the
microinjection.
Supported lipid bilayers (SLB) constitute a ﬂuid two-dimensional
space allowing free translational and rotational diffusion of lipid
molecules [51]. SLB are well suited to analyze membrane processes
such as protein adsorption, self-assembly, and protein induced
membrane reorganization [52,53]. Because of the initial well-deﬁned
bilayer geometry and conﬁnement on a solid support, this membrane
model is of particular interest when combined with surface-sensitive
microscopic and spectroscopic techniques. Temporin B (wild type and
two variants) and temporin L cause morphological transformations of
SLB composed of phosphatidylcholine and phosphatidylglycerol. More
speciﬁcally, rapid formation on SLB of ﬂexible tubular protrusions
composed of both lipid and the amphiphilic peptide is visible by
ﬂuorescence microscopy of both the ﬂuorescent lipid analog and the
labelled peptide [52]. Wild-type temporin B was found to be the most
effective, giving rise to numerous long (up to several hundred
micrometers) tubules. The extent and morphological features of
peptide-induced perturbations were found to be very sensitive to
modiﬁcations of the peptide sequence as well as to the SLB lipid
composition, with lipids having negative spontaneous curvature
attenuating the tubulation [52]. The driving force for tubulation is
likely to be augmented lateral packing in the SLB, resulting from the
insertion of the peptide into the bilayer, this pressure being relieved
by escape of tubules into the bulk phase. The tubules incorporated also
ﬂuorescent peptides and were never seen to branch, whichmay relate
to organization of temporins as linear, non-branching oligomer arrays
in their surface.
The invading bacteria are exposed to reactive oxygen species (ROS)
secreted by activated leukocytes at the sites of infection and inﬂamma-
tion [54]. As a consequence, their membrane lipids undergo a drastic
modiﬁcation due to oxidation, involving the formation of a myriad of
phospholipids containing various polar functional groups in the ends of
their acyl chains. The latter have pronounced effects on the membrane
biophysical properties, including the polarity proﬁle and overall
organization. More speciﬁcally, the oxidatively modiﬁed chains no
longer remain in the membrane hydrocarbon region but adopt the so-
called extended conformation [55], protruding into the aqueous phase
[56]. As a consequence reactive groups, such as the aldehyde present at
the end of the truncated sn-2 chain in for example 1-palmitoyl-2-(9′-
oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC), becomes
readily available for reaction with e.g. amino groups of membrane
associated peptides. Accordingly, the association of temporin B and L as
well as the cathelicidin peptide LL-37 with both lipid monolayers and
liposomes was greatly enhanced in the presence of PoxnoPC [57].
Instead, the structurally similar 1-palmitoyl-2-azelaoyl-sn-glycero-3-
phosphocholine (PazePC) containing a carboxylic moiety was less
efﬁcient. Physiological saline reduced the binding of the above
Table 1
76 current members of the amphipathic α-helical antimicrobial peptide family of temporins and results from their analyses by algorithms predicting secondary structure,
aggregation and amyloid formation.
Name Sequence Region identiﬁed by
CSSP SecStr AGGRESCAN TANGO PASTA Ref
a b c d e F g
Temporin A FLPLIGRVLSGIL-NH2 4–11 7–12 4–13 52.4 1–13 8–13 −3.64 p [6]
Temporin B LLPIVGNLLKSLL-NH2 7–13 5–13 4–13 44.1 – 4–13 −4.12 p [6]
Temporin C LLPILGNLLNGLL-NH2 7–12 5–13 – 37.2 4–13 4–10 −2.99 p [6]
Temporin D LLPIVGNLLNSLL-NH2 6–12 7–10 – 40.7 5–13 4–13 −5.48 p [6]
Temporin E VLPIIGNLLNSLL-NH2 6–12 4–10 4–13 43.5 1–13 4–13 −5.43 p [6]
Temporin F FLPLIGKVLSGIL-NH2 4–11 7–11 4–13 54.8 1–13 8–13 −3.64 p [6]
Temporin G FFPVIGRILNGIL-NH2 4–10 6–10 4–13 49.1 4–13 4–13 −4.94 p [6]
Temporin H LSPNLLKSLL-NH2 3–5 7–10 4–10 8.9 – 4–10 −1.71 ap [6]
Temporin K LLPNLLKSLL-NH2 2–5 6–10 4–10 22.3 – 4–10 −1.71 ap [6]
Temporin L FVQWFSKFLGRIL-NH2 10–12 5–10 1–13 41 1–13 1–9 −4.60 p [6]
Temporin 1ARa FLPIVGRLISGLL-NH2 4–11 5–9 4–13 53.8 5–13 4–9 −3.64 p [8]
Temporin 1AUa FLPIIGQLLSGLL-NH2 7–12 7–10 4–13 52.2 1–13 1–5 −3.02 p [9]
Temporin 1AUa PLPIIGQLLSGLL-NH2 7–12 – 4–13 42.6 5–13 4–9 −2.76 p [10]
Temporin 1BYa FLPIIAKVLSGLL-NH2 9–11 4–8 4–13 60 1–13 4–9 −4.91 p [11]
Temporin 1Ca FLPFLAKILTGVL-NH2 9–11 4–9 4–13 60.3 4–13 4–13 −3.85 p [12]
Temporin 1Cb FLPLFASLIGKLL-NH2 10–12 4–9 4–13 56.8 1–13 4–9 −3.86 p [12]
Temporin 1Cc FLPFLASLLTKVL-NH2 – 4–10 4–13 58.7 5–13 4–13 −3.93 ap [12]
Temporin 1Cd FLPFLASLLSKVL-NH2 – 4–10 4–13 57.5 5–13 4–13 −3.94 ap [12]
Temporin 1Ce FLPFLATLLSKVL-NH2 – 4–10 4–13 58.5 – 4–13 −3.93 ap [12]
Temporin 1CSa FLPIVGKLLSGLL-NH2 3–12 4–10 4–13 52.7 – 1–5 −3.07 p [13]
Temporin 1CSb FLPIIGKLLSGLL-NH2 4–11 5–10 4–13 54.5 1–13 1–5 −3.02 p [13]
Temporin 1CSc FLPLVTGLLSGLL-NH2 3–11 – 4–13 54.6 – 4–9 −2.43 p [13]
Temporin 1CSd NFLGTLVNLAKKIL-NH2 – 4–9 3–9 24.1 5–14 1–9 −4.01 p [13]
Temporin 1DRa HFLGTLVNLAKKIL-NH2 – 4–9 1–9 25.2 5–14 1–9 −4.40 p [10]
Temporin 1DRb NFLGTLVNLAKKIL-NH2 – 4–9 3–9 24.1 5–14 1–9 −4.01 p [10]
Temporin 1DRc FLPIIASVLSSLL-NH2 – 5–9 4–13 66.7 1–13 4–13 −6.73 p [10]
Temporin 1DYa FIGPIISALASLFG-NH2 – 5–8 5–14 51.8 5–13 5–13 −4.89 p [14]
Temporin 1Ec FLPVIAGLLSKLF-NH2 7–12 4–10 4–13 58 – 4–13 −3.85 p [15]
Temporin 1Ga SILPTIVSFLSKVF-NH2 – 9–11 5–14 59.4 2–14 6–14 −7.53 p [16]
Temporin 1Gb SILPTIVSFLSKFL-NH2 – 9–11 5–14 58.7 2–14 6–14 −6.27 p [16]
Temporin 1Gc SILPTIVSFLTKFL-NH2 – 7–11 5–14 59.9 2–14 6–14 −6.27 p [16]
Temporin 1Gd FILPLIASFLSKFL-NH2 – 4–11 5–14 66.8 2–14 1–14 −5.40 p [16]
Temporin 1HKa SIFPAIVSFLSKFL-NH2 – 5–11 5–14 62.3 2–14 6–14 −6.27 p [17]
Temporin 1Ja ILPLVGNLLNDLL-NH2 6–13 4–9 – 26.8 4–14 4–10 −3.05 p [18]
Temporin 1La VLPLISMALGKLL-NH2 8–13 2–5 4–13 49.5 1–7 4–9 −2.66 p [19]
Temporin 1Lb NFLGTLINLAKKIM-NH2 – 4–9 3–9 23.7 3–14 1–9 −3.95 p [19]
Temporin 1Lc FLPILINLIHKGLL-NH2 8–12 4–8 4–14 52 2–14 4–10 −8.16 p [19]
Temporin 1M FLPIVGKLLSGLL-NH2 4–11 4–10 4–13 52.7 – 1–5 −3.07 p [20]
Temporin 1Oa FLPLLASLFSRLL-NH2 – 4–10 4–13 53.2 5–13 4–9 −2.66 p [16]
Temporin 1Ob FLPLIGKILGTIL-NH2 4–12 8–12 4–13 57.2 1–13 8–13 −3.97 p [21]
Temporin 1Oc FLPLLASLFSRLF-NH2 – 2–10 4–13 54.9 5–13 4–13 −2.88 p [16]
Temporin 1Od FLPLLASLFSGLF-NH2 – 2–10 4–13 60.4 5–13 4–13 −2.80 p [21]
Temporin 1Oe ILPLLGNLLNGLL-NH2 7–12 4–10 – 35.2 4–13 7–10 −1.84 p [16]
Temporin 1Of SLLLKGLASIAKLF-NH2 2–7 – 1–6, 8–14 39.1 6–14 10–14 −2.18 p [21]
Temporin 1Og FLSSLLSKVVSLFT-NH2 9–12 5–11 1–14 53.5 8–14 1–13 −7.25 p [16]
Temporin 1OLa FLPFLKSILGKIL-NH2 8–11 5–11 4–13 53.2 4–14 4–9 −3.27 p [17]
Temporin 1OLb FLPFFASLLGKLL-NH2 10–12 3–10 4–13 56.8 1–13 4–9 −3.16 p [17]
Temporin 1P FLPIVGKLLSGLL-NH2 4–11 4–9 4–13 52.7 – 1–5 −3.07 p [19]
Temporin 1PL FLPLVGKILSGLI-NH2 4–11 4–10 4–13 54.1 4–13 8–13 −3.58 p [22]
Temporin 1PLa FLPLVGKILSGLI-NH2 4–11 4–10 4–13 54.1 4–13 8–13 −3.58 p [23]
Temporin 1PRa ILPILGNLLNGLL-NH2 3–12 8–10 – 39.3 4–13 4–10 −2.99 p [9]
Temporin 1PRb ILPILGNLLNSLL-NH2 6–12 4–10 – 41.1 4–13 4–13 −4.23 p [9]
Temporin 1Sa FLSGIVGMLGKLF-NH2 7–11 8–10 1–13 45.3 1–6 1–6 −4.15 p [24]
Temporin 1Sb FLPIVTNLLSGLL-NH2 7–12 – 4–13 52.8 5–13 4–9 −5.38 p [24]
Temporin 1Sc FLSHIAGFLSNLF-NH2 7–11 1–6 1–13 34 1–13 1–13 −5.97 p [24]
Temporin 1SKa FLPVILPVIGKLLNGIL-NH2 4–7, 12–15 11–14 8–17 61.3 12–17 4–17 −5.83 p [25]
Temporin 1SKb FLPVILPVIGKLLSGIL-NH2 4–7, 12–15 11–14 8–17 68.4 12–17 4–9 −5.80 p [25]
Temporin 1SPa FLSAITSILGKFF-NH2 8–11 5–10 1–13 47.6 1–13 1–9 −5.20 p [26]
Temporin 1SPb FLSAITSLLGKLL-NH2 10–12 2–9 1–13 40.2 1–13 1–9 −4.00 p [26]
Temporin 1SPc FLSAITSILGKLF-NH2 9–11 4–9 1–13 45.3 1–13 1–9 −5.20 p [26]
Temporin 1TGa FLPILGKLLSGIL-NH2 3–11 11–14 4–13 53.8 – 8–13 −2.38 p [27]
Temporin 1TGb AVDLAKIANKVLSSLF-NH2 11–15 7–13 9–16 19.1 – 7–16 −4.51 p [27]
Temporin 1TGc FLPVILPVIGKLLSGIL-NH2 12–15 11–14 8–17 68.4 12–17 4–9 −5.80 p [27]
Temporin 1TSa FLGALAKIISGIF-NH2 – 8–10 6–13 47.5 – 5–13 −4.22 p [28]
Temporin 1TSb FLPLLGNLLNGLL-NH2 6–11 3–10 – 34.9 – 7–10 −1.84 p [28]
Temporin 1TSc FLPLLGNLLRGLL-NH2 6–12 3–10 – 35.4 4–13 4–9 −1.64 p [28]
Temporin 1TSd FLPLLASLIGGML-NH2 8–10 3–13 4–13 54.0 5–13 4–9 −3.35 p [28]
Temporin 1Va FLSSIGKILGNLL-NH2 2–11 8–11 6–11 30.6 1–13 1–13 −3.44 p [29]
Temporin 1Vb FLSIIAKVLGSLF-NH2 8–11 1–7 1–13 61.7 1–13 1–13 −6.80 p [29]
Temporin 1Vc FLPLVTMLLGKLF-NH2 10–12 4–9 4–13 62.2 – 4–9 −4.11 p [29]
Temporin 1VE FLPLVGKILSGLI-NH2 4–11 4–10 4–13 54.1 4–13 8–13 −3.58 p [30]
(continued on next page)i
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Table 1 (continued)
Name Sequence Region identiﬁed by
CSSP SecStr AGGRESCAN TANGO PASTA Ref
a b c d e F g
Temporin Ala FLPIVGKLLSGLSGLL-NH2 4–7, 10–13 – 4–11 46.3 – 1–5 −3.07 p [31]
Temporin GH FLPLLFGAISHLL-NH2 3–12 4–10 4–13 56.4 2–13 4–13 −4.35 p [32]
Temporin GUa FLQHIIGALSHIF-NH2 7–11 1–7 3–8 32.1 – 1–13 −7.43 p [33]
Temporin GUb FLPLLFGAISHIL-NH2 3–12 3–10 4–13 59.1 2–13 4–13 −5.55 p [33]
Temporin GUc FFPLIFGALSSILPKIL-NH2 3–7, 11–15 – 4–13 62.6 1–17 4–13 −4.70 p [33]
a. Continuum secondary structure predictor identiﬁed region.
b. Region of ambivalent secondary structures.
c. Aggregation-prone segments (hot spots) predicted by AGGRESCAN.
d. Aggregation score by AGGRESCAN.
e. Amyloidogenic regions predicted by TANGO.
f. Amyloidogenic regions predicted by PASTA.
g. Free energy obtained from PASTA and relative orientation of neighbouring β-strand in the ﬁbril core, p=parallel, ap=antiparallel.
h. –, no match detected by the algorithms.
See text for details.
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PoxnoPC were found to be insensitive to the ionic strength.
Intercalation of temporin L into PoxnoPC containing membranes
was blocked by methoxyamine, suggesting Schiff base formation
between peptide amino groups and the lipid aldehyde function.
PoxnoPC and similar aldehyde bearing oxidatively modiﬁed phos-
pholipids could thus represent potential molecular targets for AMP
[57]. This suggests that ROS secretion by leucocytes and subsequent
oxidation of the phospholipids in bacteria could make the latter
vulnerable by generating molecular targets for AMP, possibly further
relating to their other membrane perturbing properties and capability
to modulate both innate and adaptive immunity via different
mechanisms, including induction of cytokine production, stimulation
of leukocyte chemotaxis, and promotion of monocyte-derived
dendritic cell maturation [58].
3. Discriminating between the target and the host cell: role of lipid
composition
The mechanism of discrimination between the target cells and
AMP-secreting eukaryote hosts is not clear. While PG is abundant in
bacteria, the outer leaﬂet of eukaryotic plasma membranes normally
lacks acidic phospholipids and it is this difference which has been
suggested to enable the survival of the host [59]. The presence of
sphingomyelin and cholesterol in the plasmamembrane of eukaryotes
is another major difference to the lipid composition of the bacterial
membrane. Interestingly, it is this combination of cholesterol and
sphingomyelin which seems to provide the most efﬁcient barrier
against the insertion of AMP [60]. Sterols increase the conformational
order of the lipid acyl chains and reduce membrane permeability [61].
Further, sterols regulate the membrane lateral organization and the
membrane hydrophobic thickness that is responsible in part for the
regulation of lipid–protein interactions [62]. Cholesterol in particular
has cohesive interactions with saturated lipids [63] and has been
shown to attenuate the membrane association of some AMP. This
effect has been suggested to protect the host cell from membrane
permeabilization by these peptides. Membrane association of tem-
porin L (as well as LL-37) in the presence of XSterol=0.5 was
dependent on the type and content of sterol in the model membranes,
with cholesterol being the most effective, followed by lanosterol and
ergosterol [64]. To this end, the chemical evolution of sterol structure
could have been driven by improving the resistance of host cell
membranes to AMP, thus promoting their survival without compro-
mising the efﬁciency of AMP for target cell killing. Combining i) high
toxicity of AMP to targets and ii) highly improved insensitivity of the
host to these peptides imparted by the outer leaﬂet lipids (cholesterol
and sphingomyelin) must have had a highly decisive impact to the cell
and species survival.4. Formation of amyloid-like ﬁbers by temporin B and L
Amyloid forming peptides/proteins constitute a particularly
important class of cytotoxic biomolecules, which similarly to AMP
are believed to exert their action by permeabilization of cellular
membranes [65]. The cytotoxic action of amyloid forming proteins
seems to be generic and due to transient protoﬁbrils in the folding/
aggregation free energy landscape preceding the formation of inert,
non-toxic mature amyloid [66,67]. The role of membranes is
emphasized by the lack of effect by amino acid chirality on the
toxicity of small amyloidogenic peptides [68]. Protoﬁbrillar inter-
mediates have been observed during the ﬁbrillogenesis of all amyloid
forming proteins and were further shown to have channel- or pore-
like properties in vitro [66]. These oligomers then convert into
amyloid, the latter corresponding to the minimum in the folding/
aggregation free energy landscape of the peptide [69]. X-ray ﬁber
diffraction studies have demonstrated that the amyloid ﬁbrils consist
of a cross-β structure aligning perpendicular to the ﬁbril long axis
[70]. The formation of ﬁbers by amyloid forming peptides and their
cytotoxic action are interconnected, membrane associated processes
[71], with lipid–protein interactions greatly enhancing the rates of
peptide aggregation and ﬁbrillogenesis observed in the presence of
membranes, especially when containing anionic phospholipids, as
demonstrated for Aβ [72], prion [73], α-synuclein [74], and IAPP [75],
for instance. Formation of amyloid-type ﬁbrils was also induced by
negatively charged phospholipids for several other cytotoxic and
apoptotic proteins [71,76]. Uptake of membrane phospholipids in
ﬁbers formed by amyloid forming proteins IAPP, transthyretin,
lysozyme, cytochrome c, endostatin, and insulin [71,76–78] could
additionally contribute to their cytotoxic action [78].
Membranes provide a unique environment that can facilitate
spatial protein enrichment and destabilization of their native
structure, induce orientational anisotropy and conformational
changes, alleviate electrostatic repulsion between chargedmonomers,
and eventually drive an ordered polymerization of the cytotoxic
proteins/peptides [71,75,76,79]. On the other hand, changes in the
secondary structure of AMP enable them to interact with and
destabilize lipid bilayers of their target cells, exposing hydrophobic
regions [80] needed for membrane incorporation and subsequent
peptide aggregation. Magainin-2, for example has no well-deﬁned
secondary structure in an aqueous solution at neutral pH, while α-
helical and β-sheet structures are observed in different populations in
acidic phospholipid bilayers [81]. Interestingly, there is recent
evidence also for several AMP [60,76,82] forming in the presence of
acidic phospholipids amyloid-type, Congo red and Thioﬂavin T
staining ﬁbrils, as demonstrated for temporin B and L, LL-37,
plantaricin A, magainin-2, sakacin P and melittin in our laboratory
[76,82], andmore recently also for dermaseptins [83]. We have further
Fig. 1. ‘Leaky slit’ membrane defect caused by an amphipathic ribbon formed by an
oligomeric peptide. The hydrophobic facet of the ribbon seals with the hydrocarbon
chain of the bilayer, while the hydrophilic facet forces the lipids to have a high positive
curvature. See text for more details (from [82]).
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same as for amyloid forming peptides and proteins in general [76,82].
On the basis of the above we have proposed the “leaky slit” model
(Fig. 1) for the membrane damaging action of AMP amyloid
protoﬁbrils [82]. More speciﬁcally, this model would represent the
minimal requirement for cytotoxicity and involves the formation of an
oligomer, a membrane spanning amphipathic ribbon with one facet
constituted by hydrophobic and the other by hydrophilic side chains,
the ribbon long axis lying parallel to the membrane plane. The actual
conformation of the peptide in the ribbon is irrelevant and also a
structure such as the α-sheet [84] could be involved. In fact, an α-
helical state has been identiﬁed as an obligatory intermediate in
amyloid formation [85,86]. The length of the amphipathic ribbon can
vary, with higher content of AMP yielding longer oligomers and
generating larger openings in the membrane. Likewise, both linear
and circular structures are allowed. The toxic state should be transient
only, with themature amyloid being rather inert and non-toxic. To this
end, amyloid formation process represents in many ways an ideal
mechanism for host defence. Secreted by e.g. macrophages at the site
of infection the local concentration of the peptides is high, sufﬁcient
for the formation of transient, toxic oligomers allowing leakage of the
contents of their target cells. At the end, the oligomers would convert
into amyloid, detoxifying the peptides. At this point it is necessary to
emphasize that mechanisms such as described above need to be
conﬁrmed and a more detailed molecular level understanding of the
process of amyloid-like ﬁber formation by AMP and the roles played
by speciﬁc lipids at different stages of aggregation/folding is needed.
5. Prediction of peptide structural characteristics
The information about the secondary structure and oligomeriza-
tion of α-helical AMP as well as other lipid-induced amyloid forming
peptides, critical for their activity, is coded in their sequences. We
subjected the current temporin family (76 peptides, Table 1) as well as
a more diverse group of α-helical AMP, in total 188 peptides (Table S1
in Supplementary material) to analyses by algorithms developed to
identify regions with conformational ambiguity, as well as propensity
to aggregation and amyloid formation, viz. CSSP [87], SecStr [88],
AGGRESCAN [89], TANGO [90] and PASTA [91] (see Supplementary
material for more details).
CSSP (continuum secondary structure prediction) identiﬁes and
gives the entropy for sequences, which can undergo a conformational
change from a random coil to an α-helix [87]. Interestingly, for 58 out
of the 76 α-helical temporins CSSP identiﬁes ambivalent regions,
which have more than 0.5 entropy of predicted class probabilities, the
disorder arising due to the lack of preference for neither the random
coil nor the α-helix (Table 1). Pursuing this structural ambivalence
further these sequences were analyzed also by SecStr to identify
amino acid stretches that have propensities for both α-helix and β-strand, i.e. regions which are potentially capable of undergoing a
conformational change, representing possible ‘conformational
switches’ [92]. Importantly, SecStr predicts 70 out of the 76 temporins
to contain class switching elements with intrinsic equal probability for
both α-helix and β-sheet (Table 1). It is further evident that the
regions, which have preference either for random coil or α-helix as
observed by CSSP are predicted by SecStr to prefer β-sheet or α-helix
(Table 1).
A structural transformation of ﬁbril forming protein is a pre-
requisite to form amyloid aggregates. Amyloidogenic proteins/pep-
tides contain short sequence motifs called ‘hot spots’ that, once
exposed, are highly prone to aggregation [93], responsible for their
amyloidogenic behaviour. Hydrophobicity, propensity to form α-
helical or β-sheet secondary structure, and net charge of the
polypeptide chain modulate aggregation of the partially or totally
unfolded state of a protein [94]. Motifs consisting of more than 90% of
hydrophobic residues are a major contributor in β-sheet structures
found in amyloid [95]. Aggregating and amyloidogenic regions
(regions of high packing density) and short speciﬁc amino acid
stretches (‘hot spots’) can act as facilitators [96]. Out of the 76
temporin sequences 68, 61 and 36 were identiﬁed with regions
potentially forming aggregates and amyloid, respectively, by the
AGGRESCAN [89], TANGO [90] and PASTA [91] algorithms, the latter
two predicting sequences with a tendency to aggregate as β-sheets
(Table 1). Some sequences, such as temporin C, D, 1Ja, 1Oe, 1PRa, 1TSb,
and 1TSc display high positive aggregation score in AGGRESCAN
without having a ‘hot spot’, which also suggests an overall high
aggregation propensity [90].
Importantly, the conformational switches predicted by CSSP [87],
and SecStr [88] in temporins coincide verywell (Table 1)with the high
packing density aggregating and amyloidogenic regions predicted by
AGGRESCAN [89], TANGO [90] and PASTA [91]. Our analyses thus
imply that the short amino acid stretches in temporins, accessible for
intermolecular interactions, show propensities for random coil, α-
helix and β-sheet formation, as well as for self-assembly, aggregation
and oligomerization into amyloid ﬁbrils.
Interestingly, very similar results were obtained for a more
extensive collection of amphipathic α-helical peptides by the above
algorithms. Of these 112 α-helical AMP 103 were identiﬁed by CSSP to
have the propensity to switch conformation from a random coil to an
α-helix while 82 were further selected by SecStr to contain motifs of
varying length and with a preference for both α-helix and β-sheet
(Table S1, Supplementary material). Notably, out of the 112 α-helical
AMP 107 were identiﬁed by AGGRESCAN to have aggregation prone
segments in their sequences, while PASTA and TANGO further
recognized 82, and 95 peptides, respectively, to contain amyloidogenic
motifs.
Importantly, the algorithms usedwere built on the basis of amyloid
structures found in vivo and they do not take into account the complex
environment prevailing in membranes, which induce the conforma-
tional changes, aggregation, and amyloid formation of α-helical AMP.
The fact that the above algorithms performed so well, in spite of the
above limitation, is likely to indicate that these features, i.e.
conformational switching, aggregation, and amyloid formation are
indeed inherent to the sequences of α-helical AMP, and dominate the
behaviour of these peptides even in a membrane environment. Yet, in
this context it is also worth noticing, that recent studies on amyloid
formation have revealed this process to be enhanced by a membrane
environment, in particular when containing acidic phospholipids [79].
Further, there is a current consensus that the toxicity of amyloid
formation derives from the interactions of the toxic oligomer
‘protoﬁbril’ with lipids, resulting in membrane permeabilization.
Accordingly, although the algorithms were not knowingly developed
with the lipid environment in mind, at the end, they have been
developed for sequences involved in a process, which in fact does take
place in membranes.
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peptides were found by CSSP, SecStr, AGGRESCAN, TANGO, and PASTA,
respectively, to contain regions complying with the view that these
peptides possess considerable conformational ﬂexibility and the
potential to form amyloid structure. Moreover, the regions identiﬁed
by the above algorithms reveal a signiﬁcant overlap (Table 1).
Importantly, this feature seems to be inherent also to other AMP
(Table S1 in Supplementary material). The recognition of ambivalent
sequences which can be easily converted between α-helical and β-
sheet structures and amyloid ﬁbrils in a proper environment can be
expected to reveal important further clues about the molecular level
mechanisms of amphipathic α-helical AMP in general. The above
sequence analyses further support the notion that the cytotoxic
actions of α-helical AMP and amyloid forming peptides/proteins are
closely related, these two classes of peptides possessing similar
speciﬁc sequence motifs encoding the amyloid core structure.
6. Concluding remarks
A given amino acid sequence can adopt different conformations
depending on its solvent environment [97], its environment inside a
protein [98] or upon the interaction between an enzyme and its
substrate [99]. A large fraction (approxim. 30%) of the human genome
is estimated to code for integral, membrane spanning proteins. The
number of peripheral membrane associating proteins is likely to be
signiﬁcantly higher. Lipids play an important role in modulating the
conformations of soluble proteins/peptides, as demonstrated for AMP
[100,101], with different membrane environments (e.g. lipid lateral
packing, lateral pressure proﬁle, density of negative charge, presence
of cholesterol and sphingomyelin, PIPs, oxidized phospholipids)
inﬂuencing the outcome. Such environment determined folding/
aggregation free energy landscapes are the hallmark of natively
unfolded peptides/proteins [102].
For AMP the toxic function is intimately coupled to folding/
aggregation. This can be rationalized in the following highly
interconnected sequence of events (Fig. 2):
i) Electrostatically enhanced initial association of a random coil
peptide to the membrane surface.
ii) Theensuingsecondstep involves several simultaneousprocesses:
intercalation into thebilayer,with thepeptide longaxis parallel to
the membrane layer plane, a conformational change from a
random coil to an amphipathic α-helix [45,103], and ion-pairing
of acidic phospholipids with positive residues of the peptide.
iii) Reorientation and membrane insertion of the peptide, its long
axis becoming perpendicular to the monolayer surface [41,48].
In this step some peptide associated acidic phospholipids can
removed from their initial location, so as to have their acyl
chains oriented more or less parallel to the plane of the bilayer
[41,50], as required for instance by the toroidal pore model.Fig. 2. Schematic illustration of the stages in the membrane association/folding/aiv) Aggregation of the α-helical peptides into oligomers. It is
possible that this intermediate represents the toxic ‘protoﬁbril’.
Further, iii) and iv) could be coupled. For the sake of clarity
possible formation of e.g. tail-to-tail dimers is not depicted.
v) The above process may further involve the formation of an α-
sheet [84].
vi) Conversion of the α-helical ﬁbril into a β-sheet, with sub-
sequent further aggregation of the ﬁbrils into inert, non-toxic
amyloid. Both v) and vi) are driven by the free energy gain from
intermolecular hydrogen bonding, analogously to the folding
driven by intramolecular H-bonds [45].
Steps ii) and iii) can be attenuated by augmented lipid lateral
packing such as prevailing in the outer leaﬂet of eukaryote plasma
membrane containing both cholesterol and sphingomyelin in the
liquid ordered phase [64], thus shifting the equilibrium towards
partitioning of the peptide into the aqueous phase. On the other hand,
membrane partitioning is promoted by the presence of acidic
phospholipids, such as PG in the bacterial membrane. Also a change
in the orientation of the peptide long axis from parallel to
perpendicular to the membrane plane is greatly promoted by
negatively charged lipids. The latter further promote peptide
aggregation by abolishing electrostatic repulsion between the cationic
peptides, in keeping with the general gatekeeping role of Arg and Lys,
capping aggregating hydrophobic sequences [104]. Peptide aggrega-
tion by acidic phospholipids further enhances a conformational
transition from an α-helix to a β-sheet, forming Congo red and
Thioﬂavin T staining ﬁbers, characteristically to amyloid.
Paradigms of amyloidogenic peptides are Aβ, α-synuclein, and
amylin (also known as IAPP, islet associated polypeptide), involved in
Alzheimer's and Parkinson's diseases, and type 2diabetes, respectively.
Similarly to temporin B and L, discussed above, also for these peptides
enhanced ﬁbril formation in the presence of acidic lipids has been
demonstrated [79]. Because of their parallel behaviour to AMP, we
have postulated, that all these peptides execute their cytotoxic
function by very similar molecular level mechanisms, with mem-
brane–lipid interactions providing the driving force. For membrane
associated amyloid diseases the toxic form is currently thought to be an
amphipathic ﬁbrillar intermediate, ‘protoﬁbril’, which permeabilizes
membranes, triggering cell death. Similarly to the Aβ peptide [79],
temporins B and L cause concentration-dependent membrane perme-
abilization, larger molecules leaking out at higher concentrations of
peptide [79]. The kinetics (cell death vs dose vs time dependence,
Fig. 3) shows a fast decay in live cell number, yet with an abrupt
levelling off of the cytotoxicity, observed at all concentrations of
temporin L added [105]. These data comply with the toxic oligomer
converting into an inactive form in a transition like manner, as e.g.
lateral diffusion of the peptide in the target cell membrane would
otherwise result in cell death to continue and slow down asympto-
tically. We have previously observed the macroscopic aggregation ofggregation pathway (adapted and modiﬁed from [103]). See text for details.
Fig. 3. Cytotoxicity of temporin L to Hut-78 (panel A) and K-562 (panel B) tumour cells.
Reprinted with permission from [105].
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seemingly inert, highly refractive aggregate [48]. In this process the
integrity of the GUV is retained and after the formation of the
aggregate there are no further macroscopic changes in the assembly.
Based on these observations we suggested that the membrane
perturbation by these peptides is transient and due to the process
itself, i.e. the binding and subsequent aggregation (oligomerization) of
the peptide in the bilayer [41,50], leading at the end to the formation of
an inert, non-toxic peptide–lipid aggregate.
Several oligomer geometries are possible and have been observed,
from circular well-deﬁned pores to large, highly leaking openings in
the membrane. This together with the sequence diversity of
temporins and AMP in general all point to the conclusion that toxicity
is due to generic physicochemical characteristics of the oligomer.
Highlighting in this respect the similarity between e.g. temporins and
short amyloidogenic peptides is the independence of their toxicity
from amino acid chirality [35,68]. The minimal physicochemical
property required for cytotoxicity is the amphipathic nature of the
oligomer, one surface being hydrophilic and the other hydrophobic.
For a channel-like oligomer the pore is lined by hydrophilic residues.
Much less deﬁned is the toxic structure constituted by an amphipathic
ribbon causing a ‘leaky slit’ type membrane defect (Fig. 1). The actual
length of the oligomer can vary, higher peptide contents making
longer ﬁbrils and allowing leakage of larger molecules, as observed
[36,65]. Most notably, the only requirement for cytotoxicity is the
amphipathic nature of the ﬁbril, with a proper thickness to match the
lipid bilayer. Accordingly, both β-sheet ﬁbrils as well as aggregated α-
helices andα-sheets [84] would be feasible. To this end, it is of interest
that an obligatory α-helical intermediate has been demonstrated for
amyloid formation [85,86]. The adoption of an α-helical structureupon binding to lipid surfaces is not limited to temporins and other
AMP of this type but is a property shared by many disease-associated
amyloid proteins. Accordingly, α-synuclein [106,107], Aβ [108], IAPP
[109], prion protein (PrP) [110], and amyloid A [111] have all been
shown to acquire increased α-helical structure upon association with
charged amphiphile surfaces, indicating common mechanisms. Last,
apart from obstructive macroscopic accumulation, the mature
amyloid is considered to be inert and non-toxic. The above scenario
is supported by the sequence analyses of temporins (Table 1), together
with several other families of α-helical amphipathic AMP (Table S1 in
Supplementary material). In brief, temporins and other amphipathic
α-helical AMP contain ‘conformational switches’, regions with equal
probability for different conformations. These domains overlap with
those predicted to aggregate and form amyloid. Proper lipid bilayer
environment involving anionic and oxidized lipids would thus control
‘conformational switching’ in AMP, causing them to expose hydro-
phobic residues and promoting membrane insertion, which subse-
quently allows self-association of the peptides by hydrogen bonding in
the target cell membrane, leading to extensive aggregation, formation
of toxic oligomers and ﬁnally non-toxic amyloid for degradation and
removal. The above partly tentative molecular level mechanisms of
membrane association and cytotoxicity highlight the great degree of
similarity between AMP and the disease-associated amyloid forming
peptides. However, it needs to be recognized that the physicochemistry
of AMPwas optimized during evolution formaximal beneﬁt to the host
defence, while the cytotoxicity of the pathology associated peptides is
likely to reﬂect a weak point in the current machinery of organisms
such as man. This means that also differences are to be expected in e.g.
the kinetics of the pathways in the folding/aggregation free energy
landscapes for peptide/membrane assemblies. Finally, an interesting
and important new area concerns the synergistic effects of AMPs, both
as combinations of different AMPs [112] as well as in combinationwith
other host defence mechanisms [113,114], which both add to the
potential of AMP and understanding of innate immunity to the
development of new means to combat microbes.
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